Edition:
United States

Oragenics Inc (OGEN.A)

OGEN.A on American Stock Exchange

0.69USD
20 Jan 2017
Change (% chg)

$0.04 (+6.54%)
Prev Close
$0.65
Open
$0.63
Day's High
$0.70
Day's Low
$0.63
Volume
1,495
Avg. Vol
16,488
52-wk High
$1.20
52-wk Low
$0.34

Latest Key Developments (Source: Significant Developments)

Oragenics says U.S. FDA grants fast track designation for development of co's AG013 for oral mucositis
Monday, 21 Nov 2016 03:33pm EST 

Oragenics Inc : U.S. FDA grants fast track designation for the development of Oragenics' AG013 for oral mucositis .Oragenics - expects to file an Investigational New Drug (IND) update and initiate a phase 2 study with AG013 in United States and Europe in early 2017.  Full Article

Oragenics - expects to file an investigational new drug (IND) update and initiate a phase 2 study with AG013 in United States and Europe in early 2017
Monday, 21 Nov 2016 07:45am EST 

Oragenics Inc : Oragenics - expects to file an investigational new drug (ind) update and initiate a phase 2 study with ag013 in united states and europe in early 2017 . Oragenics -a phase 1b clinical trial with ag013 in 25 head,neck cancer patients at high risk for om demonstrated that ag013 was safe and well tolerated .U.S. FDA grants fast track designation for the development of oragenics' ag013 for oral mucositis.  Full Article

Oragenics receives supportive FDA feedback for initiating a phase 2 study protocol for Oral Mucositis Treatment
Tuesday, 30 Aug 2016 08:15am EDT 

Oragenics Inc : Oragenics receives supportive FDA feedback for initiating a phase 2 study protocol for Oral Mucositis Treatment . Expects to file Investigational New Drug (ind) update in late 2016 . Oragenics Inc says to initiate study with ag013 in united states and europe during early 2017 .Applications for biologic license application exclusivity and fast track designation with FDA will be filed in coming months.  Full Article

Oragenics Inc files for stock shelf of upto $30 mln
Thursday, 25 Aug 2016 05:24pm EDT 

Oragenics Inc :Files for stock shelf of upto $30 million - SEC filing.  Full Article

Oragenics Inc says Alan Joslyn to be new president and CEO
Monday, 6 Jun 2016 04:51pm EDT 

Oragenics Inc : Oragenics announces new president, chief executive officer and member of the board of directors .Oragenics Inc says Alan Joslyn will be company's new president and chief executive officer.  Full Article

Intrexon Corp and Oragenics Reports Positive In Vivo Antibiotic Efficacy Data in Critical Animal Study
Tuesday, 28 Jul 2015 04:05pm EDT 

Intrexon Corp and Oragenics:Says positive data on multiple compounds from Oragenics' Mutacin 1140 lantibiotic platform in a critical animal model study, as well as the selection of a lead clinical candidate.The compounds were subjected to a standardized proof of concept animal model evaluating efficacy for reducing clinically relevant C. difficile infection(s) and increased survival relative to vancomycin positive control.  Full Article

Intrexon Corp and Oragenics expand collaboration to pursue development of biotherapeutics for Oral Cavity
Wednesday, 10 Jun 2015 08:15am EDT 

Intrexon Corp and Oragenics:Says new Exclusive Channel Collaboration (ECC) to pursue development of biotherapeutics for oral mucositis (OM) and other diseases and conditions of the oral cavity, throat, and esophagus, including clinical advancement of the ActoBiotic AG013 for the treatment of OM.OM results in the painful inflammation and ulceration of the membranes lining the oral cavity, throat, and esophagus and is among the most frequently reported adverse events associated with cancer therapy affecting up to 500,000 patients annually.At present there is no drug approved to prevent the condition broadly and therapies are primarily palliative, alleviating symptoms without addressing the underlying pathology, resulting in a significant unmet medical need.  Full Article

BRIEF-Oragenics board authorized to increase authorized shares of stock from 100 mln shares to 250 mln shares

* Oragenics - board authorized to increase authorized shares of stock from 100 million shares to 250 million shares - sec filing Source text (http://bit.ly/2jNqM0P) Further company coverage: